Investigation of efficacy and safety of NNC0165-1875 as add-on to semaglutide for weight management in subjects with obesity

Date Added
October 26th, 2021
PRO Number
Pro00113328
Researcher
Patrick O'Neil

List of Studies


Keywords
Drug Studies, Obesity, Weight Control
Summary

This is a trial to look at how well an investigational obesity medicine works with another approved obesity medicine given at the same time, each taken via subcutaneous injection once weekly for weight loss in people who are overweight or obese and are otherwise generally healthy. This is a randomized, double-blinded trial. The investigational medicine will be compared against a placebo and be administered per a dosing schedule.

Institution
MUSC
Recruitment Contact
Mary Harley
843-792-5428
harleyma@musc.edu

The Effect Of Epitomee Capsule On Body Weight In Patients With Overweight And Obesity With And Without Pre-Diabetes

Date Added
August 19th, 2020
PRO Number
Pro00094007
Researcher
Patrick O'Neil

List of Studies


Keywords
Nutrition, Obesity, Weight Control
Summary

This study is testing the effects on weight loss of a capsule-delivered device that expands in the stomach to help create a sense of fullness. The device then leaves the stomach, disintegrates and is excreted. In this study participants will receive either the device or a placebo capsule that looks the same. Participants will receive dietary and exercise counseling at most visits to help them lose weight. The 24-week losses of participants who get the device will be compared to the losses of those who get the placebo capsule to determine the effect on weight loss. Changes in other health markers will also be assessed.

Institution
MUSC
Recruitment Contact
Mary Harley
843-792-5428
harleyma@musc.edu



-- OR --